respiratory distress due to upper airway obstruction in child
Conditions
Brief summary
Cumulative incidence of DRPE/OVAS within 48 hours post-extubation
Detailed description
Cumulative incidence of reintubation due to DRPE/OVAS within 48 hours of planned extubation, Odds-Ratios associated with the occurrence of DRPE/OVAS ratio within 48 hours post-extubation, Number of days of hospitalization in URP, Calculation of the number of days free of ventilatory assistance in URP, Calculation of the number of days with non-invasive ventilation post-extubation, Incidence of side effects of DXM-IV occurring from randomization to 48 hours post-extubation.
Interventions
DRUGDEXAMETHASONE PHOSPHATE
DRUGPlacebo of dexamethasone
Sponsors
Assistance Publique Hopitaux De Paris
Eligibility
Sex/Gender
All
Age
0 Years to 17 Years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cumulative incidence of DRPE/OVAS within 48 hours post-extubation | — |
Secondary
| Measure | Time frame |
|---|---|
| Cumulative incidence of reintubation due to DRPE/OVAS within 48 hours of planned extubation, Odds-Ratios associated with the occurrence of DRPE/OVAS ratio within 48 hours post-extubation, Number of days of hospitalization in URP, Calculation of the number of days free of ventilatory assistance in URP, Calculation of the number of days with non-invasive ventilation post-extubation, Incidence of side effects of DXM-IV occurring from randomization to 48 hours post-extubation. | — |
Countries
France
Outcome results
None listed